IPOs & Deals
Page 2 of 2 · 28 articles on this desk
IPOs & Deals coverage, page 2
Harte Hanks Agrees to $5-a-Share Sale to Star Equity, With a Cash-or-Preferred Twist
The direct-marketing and BPO firm would fetch about $38.4 million in a deal that lets holders choose cash or 10% preferred stock, but a 30-day go-shop keeps the outcome open.
Datavault AI Signs Definitive Deal to Buy CyberCatch for $94.5 Million Cash, and the Release Flags Its Own Financing Risk
CyberCatch disclosed the signed arrangement agreement at 8:41 p.m. ET Monday. The document sets a price, a break fee and a September shareholder vote — but it does not show where Datavault AI, a Nasdaq company that reported $2.2 million of cash at its last quarter-end, gets the money.
Fulcrum Holders Would Get an Estimated $270 Million Dividend and 5% of Slate Medicines
Eleven weeks after the FDA told Fulcrum Therapeutics there was no viable regulatory path for its only clinical program, the company agreed Monday to merge with privately held Slate Medicines, hand over its Nasdaq listing, and — if the deal closes — pay an estimated $270.0 million to pre-merger holders immediately beforehand.
HomeTrust to Buy Blue Ridge Bankshares in $448.1 Million All-Stock Deal
Monday's exchange ratio implies $4.28 for each Blue Ridge share — about 1.39 times the $3.09 of tangible book value per share the bank reported on Aug. 10, a week after it revised its second quarter for a borrower that ceased operations.
MSG Sports Says the Rangers Spin-Off Form 10 Is Now Public, a Day After a Playoff-Driven Quarter
The company announced Friday that it had publicly filed the Form 10 for MSG Rangers Corp. and still expects to complete the separation by the end of October. A day earlier it reported fiscal 2026 results in which playoff-related revenue accounted for most of the fourth quarter's growth.
Proficient Auto Logistics Closed a $130 Million Deal and Sold a Convertible That Sits On 11.5 Million Shares
The Jacksonville auto hauler completed its purchase of Hansen & Adkins on August 13 and priced $75 million of 5.50% convertible notes two days earlier. At the initial conversion rate the notes sit on 11,534,025 shares against the 28,052,923 outstanding at June 30 — and the company's own pricing release does not name the acquisition as a use of proceeds.
argenx's $77 Tender for Forte Biosciences Expires Aug. 26. The Filings Spell Out Exactly What Has to Happen First.
The offer to purchase is dated Aug. 6 and, by argenx's own commencement release, expires one minute after 11:59 p.m. Eastern on Wednesday, Aug. 26 — fifteen business days, not the twenty the Exchange Act rulebook still prints. An SEC exemptive order dated April 16, 2026 is what makes the shorter clock lawful.
Diana Shipping Withdrew Its Genco Bid 38 Minutes After Friday's Bell
Diana says Genco's board demanded a package worth about $36.91 a share, roughly 40% above where Genco actually closed on Friday. Genco has not responded, and every figure describing its demands comes from Diana.
National CineMedia loses more than 40% of its value on a fully debt-funded $275 million acquisition
The cinema advertising company is buying digital out-of-home operator Captivate for $275 million, funded entirely with new term debt, and pausing its dividend and buyback afterward. Shares closed Wednesday at $2.22.
Private capital keeps raiding the small-cap bench, and the premiums are getting hard to ignore
Three sponsor-led take-privates announced since June carry premiums between roughly 52% and 74%, a sign that buyout firms see value in smaller listed companies the public market has been slow to price.